Connect Biopharma (CNTB) director lists stock option and share stakes
Rhea-AI Filing Summary
Connect Biopharma Holdings Ltd director Karen J. Wilson reported her equity holdings in the company. The filing lists stock options over multiple blocks of Ordinary Shares, including rights to buy 89,220 shares at an exercise price of $8.1600 per share expiring on November 1, 2030, alongside additional options at exercise prices of $4.1200, $1.2700, $1.1800, $0.9600, and $2.5000 with expirations between March 1, 2032 and March 2, 2036. She also directly holds 10,000 Ordinary Shares. Footnotes state that one option grant is fully vested and exercisable, and another will fully vest and become exercisable on March 2, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
WILSON KAREN J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 278,208 shares (Direct);
Ordinary Shares — 10,000 shares (Direct)
Footnotes (2)
- F1. The stock option is fully vested and exercisable.
- F2. The stock option fully vests and becomes exercisable on March 2, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Karen J. Wilson report owning in Connect Biopharma (CNTB)?
Karen J. Wilson reports holding several stock option awards and 10,000 Ordinary Shares of Connect Biopharma. The options cover multiple blocks of underlying shares at different exercise prices and expiration dates, reflecting a structured long-term equity compensation position.
What do the vesting footnotes in Karen J. Wilson’s Connect Biopharma filing indicate?
One footnote states that a stock option grant is fully vested and exercisable. Another notes a separate stock option will fully vest and become exercisable on March 2, 2027, highlighting both already-available and future exercisable components in her equity awards.
What are the exercise price ranges and expirations of Karen J. Wilson’s Connect Biopharma options?
Her options carry exercise prices of $8.1600, $4.1200, $1.2700, $1.1800, $0.9600, and $2.5000. Expiration dates span from November 1, 2030 through March 2, 2036, illustrating staggered, long-dated grants.